跳至主要内容
临床试验/NCT02424201
NCT02424201Unknown早期 1 期

Comparative Study on Effects of Sublingual Misoprostol in Addition to Standard Active Management of Third Stage of Labour in Low Risk Parturients in Lagos State University Teaching Hospital, Ikeja.

Lagos State University0 个研究点目标入组 660 人开始时间: 2015年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
发起方
入组人数
660
主要终点
mean blood loss

研究概览

简要总结

Postpartum haemorrhage is the leading cause of maternal haemorrhage globally. With active management of labour 3 to 16.5% of parturients still experience postpartum haemorrhage. Hence the need for an effective oxytocic in third stage of labour.

详细描述

This is a prospective randomized doubleblind controlled trial involving 660 consenting pregnant women. Eligible subjects will be ransomised into 2 groups of 330 participants. All patients will receive the standard oxytocin 10 units as part of the active management of third stage of labour. However, the study group will be administered sublingual 400 misoprostol while the control group will receive 2tablets of placebo (vitamin c). Measured mean blood loss will be comparee in the 2 groups using statistical analysis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Prevention
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
15 Years 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • singleton in longitudinal lie and cephalic presentation

排除标准

  • refusal of consents, multiple gestation

研究组 & 干预措施

control

Other

Intramuscular oxytocin 10 units, 2 tablets of placebo which will be vitamin c

干预措施: vitamin c (Drug)

study

Experimental

Intramuscular oxytocin 10 units, 400 micrograms of misoprostol

干预措施: Misoprostol (Drug)

结局指标

主要结局

mean blood loss

时间窗: 1 hour of delivery

次要结局

  • number of participants with untowards effects(1 hour of delivery)

研究者

发起方
Lagos State University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Oyedeko Muyideen Oladipo

Doctor

Lagos State University

相似试验